Effect of rimonabant on weight reduction and cardiovascular risk

Lancet. 2005;366(9483):367-8; author reply 369-70. doi: 10.1016/S0140-6736(05)67016-X.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Cannabinoid Receptor Antagonists*
  • Diet, Reducing
  • Humans
  • Obesity / diet therapy
  • Obesity / drug therapy*
  • Patient Compliance
  • Piperidines / therapeutic use*
  • Pyrazoles / therapeutic use*
  • Rimonabant
  • Weight Loss

Substances

  • Cannabinoid Receptor Antagonists
  • Piperidines
  • Pyrazoles
  • Rimonabant